| A | B | C | D | ||
|---|---|---|---|---|---|
1 | Dispensers for Safe Water | Kenya | Uganda | Malawi | |
2 | Under-5 deaths averted | ||||
3 | Percent of population that is under 5, 2019 | 12.6% | 13.6% | 13.7% | |
4 | Annual all-cause mortality in under-5s, DSW counties | 1.19% | 1.09% | 1.34% | |
5 | Relative risk of all-cause mortality | 0.86 | 0.86 | 0.86 | |
6 | Internal validity adjustment, under-5 mortality | 0.80 | 0.80 | 0.80 | |
7 | External validity adjustment | 0.56 | 0.57 | 1.11 | |
8 | Percent reduction in under-5 all-cause mortality, initial estimate | 6.0% | 6.1% | 12.0% | |
9 | Maximum plausible percent reduction in under-5 all-cause mortality | 5.6% | 8.4% | 10.9% | |
10 | Percent reduction in under-5 all-cause mortality, final estimate | 5.6% | 6.1% | 10.9% | |
11 | Annual under-5 deaths averted per 100,000 people covered, adjusted | 8 | 9 | 20 | |
12 | Moral value per under-5 death averted | 108 | 111 | 113 | |
13 | Units of value per 100,000 covered | 902 | 1017 | 2263 | |
14 | |||||
15 | Over-5 deaths averted | ||||
16 | Percent of population that is over 5, 2019 | 87.5% | 86.4% | 86.3% | |
17 | Annual all-cause mortality in over-5s, 2019 | 0.55% | 0.44% | 0.54% | |
18 | Relative risk of all-cause mortality | 0.86 | 0.86 | 0.86 | |
19 | Over-5 mortality scaling factor | 0.32 | 0.89 | 0.60 | |
20 | Internal validity adjustment, over-5 mortality | 0.50 | 0.50 | 0.50 | |
21 | External validity adjustment | 0.56 | 0.57 | 1.11 | |
22 | Plausibility cap adjustment | 0.93 | 1.00 | 0.91 | |
23 | Annual over-5 deaths averted per 100,000 people covered, adjusted | 5 | 13 | 19 | |
24 | Implied reduction in over-5 all-cause mortality, for illustration only | 1% | 3% | 4% | |
25 | Moral value per over-5 death averted | 68.4 | 70.7 | 66.1 | |
26 | Units of value per 100,000 covered | 370 | 939 | 1267 | |
27 | |||||
28 | Morbidity | ||||
29 | Annual YLDs attributed to enteric infections per 100,000, 2019 | 180 | 190 | 219 | |
30 | Relative risk reduction for diarrhea episodes | 0.81 | 0.81 | 0.81 | |
31 | Internal validity adjustment | 0.90 | 0.90 | 0.90 | |
32 | External validity adjustment | 0.49 | 0.79 | 1.02 | |
33 | Implied reduction in morbidity | 8.6% | 13.8% | 17.8% | |
34 | Annual YLDs averted per 100,000 people covered, adjusted | 15 | 26 | 39 | |
35 | Moral value per YLD averted | 2.3 | 2.3 | 2.3 | |
36 | Units of value per 100,000 covered | 35 | 60 | 90 | |
37 | |||||
38 | Development effects | ||||
39 | Units of value for development effects per treatment-year from seasonal malaria chemoprevention | 0.126 | 0.126 | 0.126 | |
40 | Development effects of in-line chlorination as a percentage of seasonal malaria chemoprevention | 44% | 44% | 44% | |
41 | Percent of population that is under 5, 2019 | 13% | 14% | 14% | |
42 | Percent of population that is 5-14, 2019 | 25.4% | 29.2% | 28.7% | |
43 | YLD rate attributed to enteric infections in under-5s, 2019 | 317 | 398 | 461 | |
44 | YLD rate attributed to enteric infections in 5-14s, 2019 | 125 | 116 | 140 | |
45 | Per capita burden of enteric infection morbidity in 5-14s as a percentage of under-5 morbidity | 39% | 29% | 30% | |
46 | Annual units of value per 100,000 covered | 1,250 | 1,228 | 1,244 | |
47 | Internal validity adjustment | 0.80 | 0.80 | 0.80 | |
48 | External validity adjustment | 0.56 | 0.57 | 1.11 | |
49 | Adjusted annual units of value per 100,000 covered | 555 | 553 | 1,097 | |
50 | |||||
51 | Medical costs averted | ||||
52 | Baseline annual diarrhea incidence per under-5 child | 4.0 | 3.6 | 4.1 | |
53 | Morbidity reduction | 8.6% | 13.8% | 17.8% | |
54 | Averted diarrhea cases per under-five child per year | 0.34 | 0.49 | 0.74 | |
55 | Annual cost of diarrhea illness averted, per under-5 | $8.15 | $5.70 | $8.05 | |
56 | Percentage of the population that is under 5, 2019 | 12.6% | 13.6% | 13.7% | |
57 | Annual cost of diarrhea illness averted, per person served | $1.02 | $0.78 | $1.10 | |
58 | Non-diarrheal illness averted multiplier | 3.7 | 3.7 | 3.7 | |
59 | Total annual cost of illness averted, per person served | $3.83 | $2.91 | $4.13 | |
60 | Internal validity adjustment for medical costs averted | 1.0 | 1.0 | 1.0 | |
61 | External validity adjustment for medical costs averted | 1.1 | 1.1 | 1.1 | |
62 | Adjusted total annual cost of illness averted, per person served | $4.21 | $3.20 | $4.54 | |
63 | Average consumption per capita, national average | $1,198 | $1,169 | $753 | |
64 | Adjustment for lower than average consumption in DSW beneficiaries | 55.8% | 53.4% | 53.0% | |
65 | DSW beneficiary annual consumption per capita, rough estimate | $668 | $624 | $399 | |
66 | Per capita increase in ln(consumption) resulting from intervention | 0.0063 | 0.0051 | 0.0113 | |
67 | Value assigned to doubling consumption for one person for one year | 1.0 | 1.0 | 1.0 | |
68 | Value assigned to increasing ln(consumption) by one unit for one person for one year | 1.44 | 1.44 | 1.44 | |
69 | Units of value from medical costs averted per person, per year | 0.0091 | 0.0074 | 0.0163 | |
70 | Units of value per 100,000 covered | 906 | 737 | 1,632 | |
71 | |||||
72 | Costs | ||||
73 | |||||
74 | Annual cost per person served | $1.68 | $1.22 | $1.86 | |
75 | |||||
76 | Results | ||||
77 | Units of value per dollar donated | 0.02 | 0.03 | 0.03 | |
78 | Total units of value per $10,000 donated | 165 | 272 | 342 | |
79 | Units of value per $10,000 donated, GiveDirectly | 33.5 | 33.5 | 33.5 | |
80 | DSW vs. cash before adjustments | 4.9 | 8.1 | 10.2 | |
81 | |||||
82 | Downside adjustments | ||||
83 | |||||
84 | Risk of wastage | ||||
85 | Double treatment | 0% | 0% | 0% | |
86 | Ineffective goods | 0% | 0% | 0% | |
87 | Goods purchased and left in storage until they expire / Cash doesn't reach recipients or is taken back from them inappropriately | 0% | 0% | 0% | |
88 | Total adjustment for risk of wastage | 0% | 0% | 0% | |
89 | |||||
90 | Quality of monitoring and evaluation | ||||
91 | Unrepresentative monitoring results | 10% | 10% | 10% | |
92 | False monitoring results | 0% | 0% | 0% | |
93 | Total adjustment for quality of monitoring and evaluation | 10% | 10% | 10% | |
94 | |||||
95 | Confidence in funds being used for intended purpose | ||||
96 | Change of priorities | 0% | 0% | 0% | |
97 | Non-funding bottlenecks | 0% | 0% | 0% | |
98 | Within-org fungibility | 0% | 0% | 0% | |
99 | Total adjustment for confidence in funds being used for intended purpose | 0% | 0% | 0% | |
100 |